Drugs / Estradiol/Norethindrone Acetate
last change Dec 2023 re-read 2 minutes ago

Estradiol/Norethindrone Acetate

Developed for
endometriosis
Investigated by
AbbVie

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03213457 Jul 2017 → Mar 2020 endometriosis AbbVie Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Estradiol/Norethindrone Acetate ClinicalTrials.gov intervention name — accepted as the source's own label NCT03213457